Juan C Osorio

7PUBLICATIONS
34CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 09, 2026
Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.

|Aug 28, 2025
Targeting Myeloid Cells for Cancer Immunotherapy.

Lucas Blanchard, Andrew Mijacika, Juan C Osorio

|Jun 17, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer.

Juan C Osorio, David A Knorr, Polina Weitzenfeld

|Jun 17, 2024
Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.

Nicolás Gómez-Banoy, Eduardo Ortiz, Caroline S Jiang

|Dec 26, 2023
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment.

David A Knorr, Lucas Blanchard, Rom S Leidner

|Mar 05, 2022
Beyond T Cells: IgA Incites Immune Recognition in Endometrial Cancer.

Juan C Osorio, Dmitriy Zamarin

Pageof 2

Frequent Collaborators

2 joint publications

Lucas Blanchard

2 joint publications

Jeffrey V Ravetch

1 joint publications

Dmitriy Zamarin

1 joint publications

David A Knorr